BERTEOTTI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.386
AS - Asia 2.274
EU - Europa 2.251
SA - Sud America 353
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 54
OC - Oceania 22
Totale 8.437
Nazione #
US - Stati Uniti d'America 3.259
IT - Italia 817
RU - Federazione Russa 763
SG - Singapore 636
CN - Cina 590
BR - Brasile 270
VN - Vietnam 235
HK - Hong Kong 224
KR - Corea 174
DE - Germania 137
BD - Bangladesh 119
IE - Irlanda 111
SE - Svezia 89
CA - Canada 74
FR - Francia 72
IN - India 69
PL - Polonia 60
FI - Finlandia 58
JP - Giappone 47
GB - Regno Unito 40
NL - Olanda 39
AR - Argentina 38
JO - Giordania 35
ID - Indonesia 34
MX - Messico 26
AU - Australia 22
IQ - Iraq 18
EC - Ecuador 15
NG - Nigeria 13
TR - Turchia 13
PK - Pakistan 12
SA - Arabia Saudita 11
ES - Italia 10
CO - Colombia 9
UA - Ucraina 9
ZA - Sudafrica 9
BE - Belgio 8
EG - Egitto 8
MA - Marocco 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
CI - Costa d'Avorio 6
PE - Perù 6
UZ - Uzbekistan 6
JM - Giamaica 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
VE - Venezuela 5
AT - Austria 4
GE - Georgia 4
NO - Norvegia 4
PH - Filippine 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
IR - Iran 3
LT - Lituania 3
MY - Malesia 3
PR - Porto Rico 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
BJ - Benin 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KE - Kenya 2
KH - Cambogia 2
LK - Sri Lanka 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
YE - Yemen 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
HU - Ungheria 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
Totale 8.337
Città #
Santa Clara 729
Singapore 467
Ashburn 448
San Jose 255
Hong Kong 203
Hefei 189
Seoul 172
Milan 142
Dublin 111
Florence 106
North Bergen 102
Ho Chi Minh City 89
Chandler 80
Munich 80
Fairfield 77
Beijing 74
Los Angeles 70
Council Bluffs 67
Rome 61
Hanoi 57
New York 55
Warsaw 52
Dallas 51
Moscow 48
The Dalles 47
Lauterbourg 45
Tokyo 43
Buffalo 41
Houston 40
Chicago 37
Phoenix 36
Altamura 34
Lawrence 34
Kent 33
Cambridge 32
Frankfurt am Main 30
Mumbai 30
Ann Arbor 29
Seattle 27
Jakarta 25
Naples 25
Shanghai 25
São Paulo 24
Princeton 23
Atlanta 22
Helsinki 21
Lappeenranta 20
Toronto 20
Bologna 19
Boston 19
Turin 19
Woodbridge 19
Melbourne 18
Paris 17
Turku 16
Medford 14
Brooklyn 13
Orem 13
Abuja 12
Amsterdam 12
Wilmington 12
Denver 11
Bengaluru 10
Montreal 10
San Francisco 10
Bari 9
Philadelphia 9
Brescia 8
Cavriglia 8
Guangzhou 8
Mexico City 8
Palermo 8
Pittsburgh 8
San Diego 8
Shenzhen 8
Brussels 7
Cagliari 7
Haiphong 7
Prato 7
Taipei 7
Thái Bình 7
Abidjan 6
Brasília 6
Cairo 6
Catania 6
Curitiba 6
Da Nang 6
Genoa 6
Johannesburg 6
Lecce 6
Miami 6
Newark 6
Nuremberg 6
Redondo Beach 6
Stockholm 6
Washington 6
Ankara 5
Baghdad 5
Belo Horizonte 5
Columbus 5
Totale 5.006
Nome #
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 264
Integration of CTA in the Diagnostic Workup of New Onset Chest Pain in Clinical Practice 250
Monoclonal Anti-PCSK9 Antibodies: Real-World Data 215
Transcatheter aortic valve implantation with core valve prosthesis: five year durability 203
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis 201
The serum metabolomic profiles of atrial fibrillation patients treated with direct oral anticoagulants or vitamin K antagonists 199
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 199
Time, magnitude and patterns of left ventricular remodeling after MitraClip implantation: clinical implications 197
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 186
Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion 186
Improving the net clinical benefit of dual/triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome: discovery and validation of prognostic factors for a tailored therapy 186
"Tailored" antiplatelet bridging therapy with cangrelor: moving toward personalized medicine. 185
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 178
TAVI for low-risk patients: comparison between patients enrolled in notion trial and in Florence real world registry 177
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 175
Heparin induced thrombocytopenia: position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 175
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 173
LDL-cholesterol target levels achievement in high-risk patients: An (un)expected gender bias 170
Heparin-induced thrombocytopenia after cardiac surgery. A single-center, retrospective cohort study 167
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 166
Machine learning approach for prediction of outcomes in anticoagulated patients with atrial fibrillation 165
Whole Exome Sequencing in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) 162
Value of coronary CT angiography in women with stable chest pain in clinical practice 159
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 159
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous Interventions 157
The role of extracellular matrix and inflammation in the stratification of bleeding and thrombotic risk of atrial fibrillation on oral anticoagulant therapy: insights from Strat-Af study 157
Ex Vivo Antiplatelet Effects of Oral Anticoagulants 156
Implementation of low dose coronary CT angiography in the workflow for the assessment of new onset chest pain in clinical practice 154
Adenosine in Interventional Cardiology: Physiopathologic and Pharmacologic Effects in Coronary Artery Disease 151
Association of different oral anticoagulants use with renal function worsening in patients with atrial fibrillation: A multicentre cohort study 149
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 146
Digital droplet PCR versus quantitative PCR for lipoprotein (a) kringle IV type 2 repeat polymorphism genetic characterization 145
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions 144
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 139
Markers of Inflammation and Hypofibrinolysis Are Associated with Cognitive Dysfunction and Motor Performances in Atrial Fibrillation Patients on Oral Anticoagulant Therapy: Insights from the Strat-AF Study 137
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy 137
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 137
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy 136
Left Ventricular Diastolic Dysfunction Predicts Global Longitudinal Strain Recovery after Surgical Aortic Valve Replacement 134
Trombosi Iliaco femorale 132
Lipoproteina(a) e rischio cardiovascolare: una roadmap per la gestione del paziente. Documento congiunto della Società Italiana per lo studio dell'Aterosclerosi (SISA), della Società Italiana di Cardiologia (SIC), della Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) e di SIBioC 126
Real-World Efficacy and Safety of Inclisiran: A Single-Country, Multicenter, Observational Study (CHOLINET Registry) 125
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome 120
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 119
Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report 111
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 106
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 101
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 94
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome 72
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 71
Bicuspid Aortic Valve: Old and Novel Gene Contribution to Disease Onset and Complications 67
Impact of adherence to a Mediterranean Diet pattern on patients with first acute myocardial infarction 52
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 50
Monitoring antiplatelet therapy: where are we now? 47
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 46
Disease trends over time and CD4 + CCR5 + T-cells expansion predict carotid atherosclerosis development in patients with systemic lupus erythematosus 42
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 40
Applicability of the 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines in the real world: results from a multiethnic case-control study 37
A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia 31
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry 31
PCSK9-Targeting Drugs and Gender: Are There Any Differences? 29
Effect of adherence to Mediterranean diet on first ST-elevation myocardial infarction: Insights from multiethnic case-control study 27
Pleiotropic Effects of Oral Anticoagulant Therapy: Is There a Difference Between VKAs and DOACs? 27
The predictive role of renal function and systemic inflammation on the onset of de novo atrial fibrillation after cardiac surgery 21
Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome 21
Effects of inclisiran therapy on metabolomic and lipoproteomic profiles in dyslipidemic patients 16
Totale 8.437
Categoria #
all - tutte 24.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 13 6 14 0 8 15 18 37 62
2022/2023479 35 117 24 25 15 72 69 25 63 10 17 7
2023/2024308 8 22 31 13 23 37 20 60 9 49 29 7
2024/20252.416 80 223 147 370 543 350 108 157 122 68 100 148
2025/20263.864 317 496 409 321 463 133 421 180 242 233 252 397
2026/2027885 293 112 347 133 0 0 0 0 0 0 0 0
Totale 8.437